Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma

This study has been terminated.
(Enrolment halted prematurely and not resumed. 2 patients enrolled. No data was obtained.)
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
PharmaMar
ClinicalTrials.gov Identifier:
NCT00027508
First received: December 7, 2001
Last updated: February 23, 2015
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2002
  Primary Completion Date: February 2002 (Final data collection date for primary outcome measure)